OMCL

OmnicellA

Nasdaq / Health Care Equipment & Services

At close

2026-07-22

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$60.00

+46.8% vs current

Most likely

Base case

50%

Probability

Target price

$48.00

+17.5% vs current

B-

Bear case

25%

Probability

Target price

$34.00

-16.8% vs current

AI sentiment snapshot

Latest data as of 2026-07-22

AI commentary

News tone is modestly positive after Q1's reported growth, profitability improvement, and raised guidance, but the current evidence is primarily company filings and an upcoming earnings announcement. No sufficient social coverage, post-release market-reaction attribution, or analyst revision data is available; maintain a monitoring stance into July 30.

RankAlpha Sentiment Codex - 2026-07-22

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-04-28eventQ1 profitability step-upHigh impact

Q1 2026 revenue rose 15% year over year to $310 million, while GAAP EPS, non-GAAP EPS, and non-GAAP EBITDA improved materially; management also raised full-year 2026 non-GAAP EBITDA and EPS guidance [#SEC-8K-2026-04-28].

2026-07-30catalystQ2 2026 results and guidance confirmationHigh impact

Omnicell is scheduled to release Q2 2026 results on July 30 before market open. The print is the next test of demand and profitability following Q1 results and raised full-year profitability guidance [#PR-EARNINGS-2026-07-13] [#SEC-8K-2026-04-28].

2027-05-06catalystTitan XT and OmniSphere adoption runwayHigh impact

Customer engagement for Titan XT is underway as health systems consider longer-term capital plans, while OmniSphere is positioned as a cloud-native enterprise platform. Adoption timing remains uncertain, so this is a longer-term option rather than a near-term certainty [#SEC-8K-2026-04-28] [#10-K-2026-02-26].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-07-22 • Updated nightlySource: Internal modelMethodology